Doctor profile · Federal record
Dr. Sudhir Manda, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Tucson, AZ
- NPI 1164630679
- Accepts Medicare
- MIPS 95.7 / 100 · 2023
- 24 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
603 N Wilmot RD, Ste. # 151
Tucson, AZ 857112701
(520) 886-0206
fax (520) 886-0829 - Mailing address
-
Po Box 910221 Ste # 350
Dallas, TX 753910001
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- March 9, 2022
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Arizona #50809 · New Hampshire #RT2294
- Medicaid
- OH #2855629
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164630679. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
43,193
Distinct HCPCS
10
Medicare allowed
$673,257
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 8,580 | 15 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,050 | 13 | $3 | |
J0185 |
Injection, aprepitant, 1 mg | 6,370 | 27 | $2 | |
J9271 |
Injection, pembrolizumab, 1 mg | 4,290 | 16 | $55 | |
J9267 |
Injection, paclitaxel, 1 mg | 4,064 | 14 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,860 | 19 | $23 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,330 | 14 | $42 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,224 | 54 | $0 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 1,100 | 11 | $21 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 985 | 37 | $0 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 951. This provider delivers 45× the peer median.Open Payments
Industry payments received
All-time total
$1,743
Transactions
82
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $275.95 | |
| Celgene Corporation | 15 | $193.04 | |
| PFIZER INC. | 11 | $188.60 | |
| AstraZeneca Pharmaceuticals LP | 8 | $172.36 | |
| ABBVIE INC. | 7 | $151.61 | |
| Genmab U.S., Inc. | 4 | $104.53 | |
| TAIHO ONCOLOGY, INC. | 2 | $60.09 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51.15 | |
| Incyte Corporation | 2 | $50.49 | |
| BeiGene USA, Inc. | 2 | $48.72 | |
| Mirati Therapeutics, Inc. | 3 | $46.39 | |
| SpringWorks Therapeutics, Inc. | 2 | $45.80 | |
| Genentech USA, Inc. | 2 | $44.99 | |
| Eisai Inc. | 2 | $42.45 | |
| Blueprint Medicines Corporation | 2 | $40.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
497
Patients
138
Total drug cost
$2,903,643
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Revlimid (Lenalidomide) | Brand | 103 | 19 | $1,813,479 |
| Prochlorperazine Maleate | Generic | 73 | 41 | $1,068 |
| Acyclovir | Generic | 59 | 21 | $1,061 |
| Pomalyst (Pomalidomide) | Brand | 41 | 0 | $836,223 |
| Ondansetron Hcl | Generic | 32 | 22 | $249 |
| Dexamethasone | Generic | 27 | 16 | $1,140 |
| Anastrozole | Generic | 26 | 0 | $544 |
| Levofloxacin | Generic | 25 | 0 | $346 |
| Ondansetron Odt (Ondansetron) | Brand | 22 | 19 | $316 |
| Eliquis (Apixaban) | Brand | 17 | 0 | $10,385 |
Hospital affiliations
Frequently asked questions
What is Dr. Sudhir Manda's medical specialty?
Dr. Sudhir Manda practices Hematology & Oncology Physician in Tucson, AZ.
Where does Dr. Sudhir Manda practice?
Dr. Sudhir Manda practices at 603 N Wilmot RD, Tucson, AZ 857112701. Office phone: 5208860206.
What is Dr. Sudhir Manda's NPI?
Dr. Sudhir Manda's National Provider Identifier (NPI) is 1164630679, issued by NPPES.
Does Dr. Sudhir Manda accept Medicare assignment?
Yes. Dr. Sudhir Manda accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sudhir Manda commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.